POSTPONED: Scientific and Ethical Considerations for the Inclusion of Pregnant Women in Clinical Trials
April 16 @ 9:00 am - 5:00 pm EDT
Pregnant women historically have been excluded from clinical trials for new and existing therapeutics, but many women still use medically necessary drugs during the course of pregnancy. Clearer scientific understanding of the risks and benefits associated with the use of medications during pregnancy, for pregnant women and their developing fetuses, is essential to the safe and effective management of chronic and acute medical conditions.
The Duke-Margolis Center for Health Policy, under a cooperative agreement with the U.S. Food and Drug Administration (FDA), is convening this public meeting to discuss the need for clinical research in pregnant women as well as scientific and ethical considerations for the inclusion of this complex population in clinical trials. This event also will be webcast. In person attendance is limited, so please register at your earliest convenience.